Physician profile
Patrick A Oliver
NPI 1154518751
$1,069.07
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $180 · 2021: $284 · 2022: $318 · 2023: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $254.79 | 2019-2023 | Spravato |
| Abbvie INC. | $159.60 | 2022-2023 | |
| Pharmacosmos Therapeutics INC. | $86.65 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $83.85 | 2021-2023 | Trintellix |
| Janssen Scientific Affairs, LLC | $83.45 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $74.97 | 2021 | |
| Octapharma USA, INC. | $74.42 | 2020-2021 | |
| Horizon Therapeutics Plc | $54.74 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.63 | 2022 | |
| Lundbeck LLC | $30.68 | 2022 | |
| Glaxosmithkline, LLC. | $24.90 | 2020 | |
| Pfizer INC. | $22.88 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.40 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.91 | 2022 | |
| Grifols USA, LLC | $15.87 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.